WHO WE ARE
We love inspiring the bioscience leaders of tomorrow.
​
We are the world's first Intangible Asset Management Advisory focused exclusively on biosciences. We love doing stellar work for stellar clients all over the world, all while having as much fun and adventure as possible! We realise that these are not typical values for an Intellectual Property or Intangible Asset firm, but we believe that our very nature as human beings is centred around these unique attributes. We enjoy helping clients identify, protect, and monetise their original IP, and this is reflected in the quality of our work and our enthusiasm for life sciences. Our team is small, but delivers high-impact insights along the value chain in bioscience innovation - from innovation, stage-gating, IP strategy, Intangible Asset security and protection, to market evaluation, product creation, and IPO. Our experts have worked with Fortune 500 companies, governments, and biosciences startups at many different parts in their journeys.
Carel Smit - Founder & CEO
Carel Smit is the founder and managing director of Biophile. ​A Cambridge-educated life sciences patent attorney and medtech entrepreneur with masters degrees in genetics, law, and management, he has more than 20 years of experience in bioscience IP, Intangible Asset development, and commercialisation in Australia and abroad. As a former S&P Global 100 in-house IP counsel, he understands the pressures on innovators and IP counsel, mixed with the interplay of commercial objectives. Having also co-founded an award-winning medical devices company that has helped patients in more than 15 countries, he also appreciates the pressures on founders.
​
Carel has served clients in numerous countries and for local clients Carel's knowledge and training in biotechnology, digital health, cell and gene therapy, virology, and biochemistry mean that he is comfortable with many different types of life sciences technologies, either when consulting, assisting with capital raising, or advising on Intangible Asset monetisation strategies. His IP, commercialisation, and BD strategies have been featured by Forbes, the Australian Institute of Company Directors, ABC, and the Australian federal government.
Dr Nigel Chen-Tan - IP Strategy & Analytics
Intellectual Property Strategist | Patent and Trade Marks Attorney (AU/NZ) | Physicist & Materials Scientist - Australia
Nigel is a registered Australia and New Zealand patent and trade marks attorney with a passion for empowering businesses to maximise their intellectual property potential. With a background in applied physics and material science, Nigel combines his technical expertise with over a decade of experience in intellectual property law. He specialises in assisting start-ups and SMEs in the manufacturing sector, providing tailored IP strategies that drive business growth and innovation.
Nigel offers a personalised approach to IP management, guiding clients through identifying, protecting, and commercialising their innovations. Whether it’s preparing IP applications or developing long-term business strategies, Nigel is dedicated to helping his clients achieve their commercial goals.